The psychopharmacology-molecular biology interface: exploring the behavioural roles of dopamine receptor subtypes using targeted gene deletion (‘knockout’)
- 1 May 2001
- journal article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 25 (4) , 925-964
- https://doi.org/10.1016/s0278-5846(01)00152-x
Abstract
No abstract availableKeywords
This publication has 109 references indexed in Scilit:
- Beyond the Dopamine ReceptorPublished by Elsevier ,1999
- Genetics of Mouse Behavior: Interactions with Laboratory EnvironmentScience, 1999
- Paradoxical Locomotor Behavior of Dopamine D1 Receptor Transgenic MiceExperimental Neurology, 1999
- NEW INSIGHTS INTO DOPAMINERGIC RECEPTOR FUNCTION USING ANTISENSE AND GENETICALLY ALTERED ANIMALSAnnual Review of Pharmacology and Toxicology, 1999
- Clozapine, haloperidol, and the D 4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin releaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1998
- D4/5-HT2A Receptor antagonists: LU-111995 and other potential new antipsychotics in developmentDrugs of the Future, 1998
- Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporterNature, 1996
- Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responsesCell, 1994
- Therapeutic potential of selective D-1 dopamine receptor agonists and antagonists in psychiatry and neurologyGeneral Pharmacology: The Vascular System, 1988
- Multiple receptors for dopamineNature, 1979